Injective INJ
Current Price
$5.07 -14.55%
$0.8800 Daily Range (17.36%)
$5.07$5.95
$75.81M Daily Volume
898 BTC
Vol/MktCap: 14.95%
Market Performance
0.09% Relative BTC Volume
The total volume of Injective is $75.81M over the past 24 hours, compared to $80.41B total Bitcoin volume.
Hourly Moving Average
8 SMA $5.21 -2.76%
13 SMA $5.28 -4.00%
21 SMA $5.51 -7.98%
55 SMA $5.77 -12.20%
144 SMA $5.92 -14.32%
Price Performance
-1.66% 1 Hour Change
$5.07 from $5.16
-8.67% 7 Day Change
-$0.4396 from $5.51
-25.26% 14 Day Change
-$1.28 from $6.35
-34.88% 30 Day Change
-$1.77 from $6.84
All Time High
March 14, 2024
$52.62 -90.36%
-$47.55 vs. now
24H Change
-84.83M USD -14.33%
-1,004 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.01 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
13.76M INJ
traded over past 24 hours
13.76% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $5.14, reflecting a significant 24-hour decline of 13.87%. The daily price range is tight, with a high of $5.97 and a low of $5.11, indicating a volatile market sentiment.
Trading volume has reached approximately $70.93 million, contributing to a volume-to-market cap ratio of 13.77%. This elevated volume, coupled with the negative price action, suggests increased selling pressure and lack of buying confidence in the current market.
Analyzing the hourly moving averages reveals a bearish trend, with the 8 SMA at $5.21, indicating a decline of 1.42%. The longer-term SMAs are also trending downward, with the 144 SMA at $5.92 reflecting a 13.14% drop, confirming the prevailing bearish sentiment over various time frames.
The Relative Strength Index (RSI) metrics indicate oversold conditions, particularly with a 1-hour RSI of 10. Meanwhile, the 7-day RSI of 44 suggests that the asset is nearing oversold territory, though it does not yet signal a robust buy opportunity.
Over the past week, INJ has declined by 7.02%, and the 14-day and 30-day changes are even more severe at -22.28% and -34.79%, respectively. This downward trajectory underscores the asset's vulnerability in the current market conditions, reinforcing the prevailing bearish sentiment.
Despite the potential for a rebound given the oversold RSI, the substantial declines and bearish moving averages indicate that caution is warranted. The all-time high of $52.62, reached in March 2024, feels increasingly distant, emphasizing the need for a sustained recovery before considering significant investments.
Given the current price action, negative momentum, and lack of bullish signals, a Sell rating is appropriate. This recommendation is based on the technical indicators suggesting continued downward pressure and a lack of immediate catalysts for recovery.
Trading volume has reached approximately $70.93 million, contributing to a volume-to-market cap ratio of 13.77%. This elevated volume, coupled with the negative price action, suggests increased selling pressure and lack of buying confidence in the current market.
Analyzing the hourly moving averages reveals a bearish trend, with the 8 SMA at $5.21, indicating a decline of 1.42%. The longer-term SMAs are also trending downward, with the 144 SMA at $5.92 reflecting a 13.14% drop, confirming the prevailing bearish sentiment over various time frames.
The Relative Strength Index (RSI) metrics indicate oversold conditions, particularly with a 1-hour RSI of 10. Meanwhile, the 7-day RSI of 44 suggests that the asset is nearing oversold territory, though it does not yet signal a robust buy opportunity.
Over the past week, INJ has declined by 7.02%, and the 14-day and 30-day changes are even more severe at -22.28% and -34.79%, respectively. This downward trajectory underscores the asset's vulnerability in the current market conditions, reinforcing the prevailing bearish sentiment.
Despite the potential for a rebound given the oversold RSI, the substantial declines and bearish moving averages indicate that caution is warranted. The all-time high of $52.62, reached in March 2024, feels increasingly distant, emphasizing the need for a sustained recovery before considering significant investments.
Given the current price action, negative momentum, and lack of bullish signals, a Sell rating is appropriate. This recommendation is based on the technical indicators suggesting continued downward pressure and a lack of immediate catalysts for recovery.
Updated 141 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Wirex and Algorand Expand Stablecoin Payments with New USDC Integration
Wirex, the global leader in stablecoin payment infrastructure, has announced a strategic partnership with Algorand Foundation to bring USDC on Algorand to more than 7 million…

South Korea pushes for draft stablecoin bill by Dec. 10 deadline
South Korean lawmakers set a Dec.

Strategy Still the Premier Bitcoin Proxy, Benchmark Says, Rejecting ‘Doom’ Narrative
The broker said fears over Strategy’s solvency are misplaced and the stock remains the strongest asymmetric bet on bitcoin.

Bitcoin, Ethereum, and XRP Crash Triggering $637M in Liquidations
A weekend crypto crash triggered $524M in liquidations, with fears over Tether's stability and DAT selling pressure acting as key catalysts.